검색
Ascentage Pharma Group International
AAPG관심 목록에 추가
18.050USD
+0.090+0.50%
시장 운영 시간 （ET）시세는 15분 지연됩니다
6.74B시가총액
--P/E TTM
자세한 내용은 Ascentage Pharma Group International 회사
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.
Ascentage Pharma Group International 정보
종목 코드 AAPG
회사 이름Ascentage Pharma Group International
상장일Oct 28, 2019
CEOYang (Dajun)
직원 수- -
유형Depository Receipt
회계 연도 종료- -
주소68 Xinqing Road, Suzhou Industrial Park
도시SUZHOU
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가China
우편 번호- -
전화
웹사이트https://www.ascentage.cn/
종목 코드 AAPG
상장일Oct 28, 2019
CEOYang (Dajun)
Ascentage Pharma Group International의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Dajun Yang, M.D., Ph.D.
Dr. Dajun Yang, M.D., Ph.D.
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Shaomeng Wang, Ph.D.
Dr. Shaomeng Wang, Ph.D.
Non-Executive Director, Co-Founder
Non-Executive Director, Co-Founder
--
--
Dr. Dazhong (Simon) Lu, Ph.D.
Dr. Dazhong (Simon) Lu, Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Changqing Ye
Mr. Changqing Ye
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Wei Ren
Mr. Wei Ren
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. Yifan Zhai, M.D., Ph.D.
Dr. Yifan Zhai, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Raymond Jeffrey (Jeff) Kmetz
Mr. Raymond Jeffrey (Jeff) Kmetz
Chief Business Officer
Chief Business Officer
--
--
Mr. Thomas Joseph (Tom) Knapp, J.D.
Mr. Thomas Joseph (Tom) Knapp, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
Ms. Marina S. Bozilenko
Ms. Marina S. Bozilenko
Independent Non-Executive Director
Independent Non-Executive Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Dajun Yang, M.D., Ph.D.
Dr. Dajun Yang, M.D., Ph.D.
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Shaomeng Wang, Ph.D.
Dr. Shaomeng Wang, Ph.D.
Non-Executive Director, Co-Founder
Non-Executive Director, Co-Founder
--
--
Dr. Dazhong (Simon) Lu, Ph.D.
Dr. Dazhong (Simon) Lu, Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Changqing Ye
Mr. Changqing Ye
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Wei Ren
Mr. Wei Ren
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
자주 묻는 질문
Ascentage Pharma Group International의 상위 5대 주주는 누구인가요?
Ascentage Pharma Group International의 상위 5대 주주는 다음과 같습니다: Dr. Dajun Yang, M.D., Ph.D.
Ascentage Pharma Group International(AAPG)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Ascentage Pharma Group International의 주식을 보유한 기관은 총 25곳이며, 이들이 보유한 주식의 총 가치는 약 65.84K로 전체 발행 주식의 0.07%를 차지합니다. 이는 2025Q4 대비 -220958.00 증가한 수치입니다.